Navigation Links
500 Pound Man Rescued After 12 Hour Ordeal From Wisconsin River

A 500 pound man stuck after a tubing accident was rescued from St. Croix River in western Wisconsin. Martin Rike developed symptoms of heart attack when in the river and he was rescued by dozens of rescue workers who spent hours carrying him to a navigable part of the waterway.

Martin Rike, 39, of Pine City, Minnesota, was part of a group who were rafting down the river. They were floating down the river on the Minnesota border in inner tubes Monday afternoon when Rike's hit a rock and deflated. While he was trying to get out of the water and walk along the shore, he apparently suffered chest pains and a possible heart attack and fell into the river.

Rike's group called police to report that he was having chest pains. A paramedic who arrived by helicopter stabilized Rike, but the pilot could not take him to a hospital, saying he was too heavy.

The river conditions and the mans weight complicated the effort to get him out.

As many as 50 rescuers on the ground responded, with the first reaching Rike about 9 p.m. Crews tried to get to Rike with boats and canoes, but the watercraft ran aground in shallow water.

Rescuers tried loading him into an aluminum boat, hoping to carry him over the rocky ground. But he was so heavy that they could move the makeshift stretcher only several feet downstream per hoist.

Finally, rescuers created a floating platform by lashing three canoes together and placing four boards across them.

That remedy worked much better, but it was still a lot of work, said Chief Deputy Steve Ovick of the Pine County Sheriff's Office in Minnesota. "They still had to drag those canoes all that way."

It was a 12 hour ordeal before they could move him to the ambulance. He was taken to the Burnett Medical Center in Grantsburg on Tuesday morning where he was treated for chest pain. He was discharged by afternoon.

This was rikes first tubing trip. He
'"/>




Page: 1 2

Related medicine news :

1. Low-Intensity Exercise The Key To Losing More Pounds
2. Billions of Pounds Squandered on NHS
3. A million Pound Public consultation - declared a sham!!
4. Shedding Pounds from Diet or Exercise—Take Your Pic
5. India -Penny Wise and Pound Foolish on Health Matters
6. British Funds 250 Million Pounds to Reduce Child Mortality
7. Exercise After Meals Helps Better to Lose Pounds
8. It Takes 750 Pounds a Year to Keep Your Loved One Happy
9. Sleep in Mary, Queen of Scots Bed for 7,500 Pounds a Night!
10. Apples and Lentils Could Help You to Shed Off Those Extra Pounds!
11. A Spoonful of Sugar can Melt Away the Pounds
Post Your Comments:
(Date:12/2/2008)... , SAN DIEGO, Dec. 2 Strolle...owing exercise program for new moms and their babi...aby care for more than 40 years, has signed on as ... The new partnership will strengthen the companies...d moms. , , "We are thrilled to have Pamper...
(Date:12/2/2008)...omized Comparator Study to Evaluate Efficacy of Co... , WOODCLIFF LAKE, N.J., Dec. 2 ...d that it plans to initiate the first clinical tri...ne for injection) compared to Vidaza(R) (azacitidi...diate-2 or high-risk myelodysplastic syndromes (MD...
(Date:12/2/2008)...VILLE, Tenn., Dec. 2 Emdeon, a lea...ment solutions for the healthcare industry,annou...nitor business,efficiency in healthcare. Emdeon u...( www.ushealthcareindex.com ) to establish a natio...sition from a paper-based and phone-based,system ...
(Date:12/2/2008)...ERS, Ind., Dec. 2 A number of rece...in childhood obesity, the health risks in,overwei...ue of cereals and,other foods kids consume. Yet ...fers all natural, freeze-dried real fruit products...ut also provide most, if not all, of the daily fru...
Breaking Medicine News(10 mins):Health News:Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 2Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 4Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3
...en spending precious time online, which you fear w...r fears // for a while and read this. A Northweste...e spent valuable 7 years, observing an online club...ears. According to Justine Cassel, professor of co...
...ate professor of surgery and researchers at the Un...unology and Transplantation has successfully rever...ells from pigs. // Suppression of graft rejectio...unosuppressive protocol. They have reversed the ty...
...st the use of Teflon. The Environmental Protection... main ingredient used to make the substance nonsti...nd that when the coated cookware was heated to mor...son faces an unknown risk of cancer. Teflon was ...
...ks between land-based pollution, and diseases in o...ians, and veterinarians, that implies an unhealthy... Sandifer, Chief Scientist for the new Oceans and ...al Oceanic and Atmospheric Administration (NOAA),"...
Other Medicine News:Health News:Youngsters, now have a good reason to interact online 2Health News:Diabetes cure can be achieved using pig islets 2
(Date:12/1/2008)...re/ -- New research has found that the availabilit...T) scanner in an emergency room can significantly ...a potentially life-saving treatment. Results of th...NSMC)-Salem Hospital in Salem, Mass., will be pres...cal Society of North America (RSNA). , , "T...
(Date:12/1/2008)...BIO Pte Ltd today announced the initiation of a Ph...lly-active JAK2 inhibitor, in leading medical cent...hic myelofibrosis (CIMF). , , The trial is...of SB1518 in patients with CIMF and is expected to... study will assess the safety profile and evaluate...
(Date:12/1/2008)...olicy , , ROCHESTER, Minn., Dec. 1 /PRNews...inds the use of the drug therapy etanercept ineffe...flammation of the liver caused by excessive consum...lished in the December issue of Gastroenterology ...DEO ALERT: Additional audio and video resources, i...
(Date:12/1/2008)...l/ -- GeoVax Labs, Inc.,(OTC Bulletin Board: GOVX...ng,human vaccines for diseases caused by HIV-1 (H... agents, announced today that the launch of its Ph...elve sites across North and South America.,These ...ional Institutes of,Health (NIH), and the HIV Vac...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 1BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 2BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 3BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 4Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 1Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 2Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 3Emageon Reports Third Quarter 2007 Financial Results 5593 1Emageon Reports Third Quarter 2007 Financial Results 5593 2Emageon Reports Third Quarter 2007 Financial Results 5593 3Emageon Reports Third Quarter 2007 Financial Results 5593 4Emageon Reports Third Quarter 2007 Financial Results 5593 5Emageon Reports Third Quarter 2007 Financial Results 5593 6Emageon Reports Third Quarter 2007 Financial Results 5593 7Emageon Reports Third Quarter 2007 Financial Results 5593 8Emageon Reports Third Quarter 2007 Financial Results 5593 9Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 1Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 2Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 3Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 4
...dest, Most Comprehensive Survey Provides New Bench... June 21, 2007 /PRNewswire-USNewswire/ -- The,foll... -- First nationwide study of the prevalence of ...s (MRSA), a virulent multi-drug resistant organism...MRSA prevalence study findings significantly excee...
... LEE, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Neurol...ation in the June 23 issue,of the journal The Lanc...erapy trial for Parkinson,s disease and the first ...n brain cells for any adult,neurodegenerative dise...2 patients with,advanced Parkinson,s disease demon...
Other Medicine Technology:Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6
Indicated for treatment of patella instability
OmoTrain is a unique support for the shoulder that promotes mobility and limits rotation.
... someone suffers an episode of acute low back pain...ickly restores functional mobility by providing po...,With just a few sizes that correspond directly to... will reduce inventory requirements while simplify...
Shoulder Immobilizer with Body Strap Navy blue cotton. Thumb look helps keep hand in neutral position. Padded, 2" blue pile material laminated to foam shoulder and body strap. Fits left or right. 5/p
Medicine Products: